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Governor Baker Testifies Before Senate Health, Education, Labor and 
Pensions Committee on Health Care Reform 
 
WASHINGTON D.C.— Governor Charlie Baker today testified before the Senate 
Health, Education, Labor and Pensions (HELP) Committee to highlight the importance 
of bipartisan solutions to address health care reform in Washington.  
 
The following written testimony was submitted to the United States Senate’s HELP 
Committee in advance of testifying at the Committee’s Stabilizing Premiums and 
Helping Individuals in the Individual Insurance Market hearing with a bipartisan 
group of governors, including Montana Governor Steve Bullock, Tennessee Governor 
Bill Haslam, Utah Governor Gary Herbert and Colorado Governor John Hickenlooper.  
 
Written testimony as submitted to the committee: 
  
Chairman Alexander, Ranking Member Murray and members of the committee, 
thank you for this opportunity to provide testimony before the Senate’s Health, 
Education, Labor and Pensions Committee hearing on Stabilizing Premiums and 
Helping Individuals in the Individual Insurance Market.  
 
Thank you for your willingness to engage in a bipartisan way in order to find much-
needed solutions.  I am especially appreciative that you have convened a group of 
governors to testify as we are on the front lines and are eager to work with Congress 
and the federal government on health care reform. 
 
As a former state secretary of Health and Human Services, former CEO of a health 
  
plan and current governor of a state justifiably proud of its excellent and robust 
health care system, I care deeply about access to and the affordability of health 
care.  These are challenges that must be tackled in a bipartisan, collaborative way, 
between the states and the federal government, and with full participation from 
patients, employers, insurers and providers.  I appreciate the opportunity to share 
my thoughts with you this morning. 
 
The Massachusetts Health Care Landscape   
Massachusetts believes strongly in health care coverage for its residents.  For more 
than ten years, the Commonwealth has been engaged in designing and implementing 
health care reform solutions, first on a state level with our comprehensive, bipartisan 
state reform in 2006, and later with implementation of the Affordable Care 
Act.  Working with the federal government, we have made considerable progress 
toward the goal of near universal health care coverage for our residents.  99% of our 
children and youth, and more than 96% of all of our residents have health care 
insurance, the highest percentages in the country.  Today more than 257,000 
individuals are covered through our state exchange, with 190,000 low to modest 
income residents receiving federal and state subsidies.  An additional 300,000 adults 
have Medicaid as a result of the expansion permitted through the Affordable Care 
Act.  The Massachusetts state-based exchange, known as the “Connector” maintains 
a robust individual insurance market with 62 plans offered from 10 carriers for the 
current plan year.   
Additionally, while health coverage is important first and foremost for its benefits to 
residents, health care is an economic engine for Massachusetts due to our standing 
as a global center of excellence in field medical research and home to some of the 
best treatment facilities in the world.  The health care industry contributed $19.77 
billion to the state’s economy in 2014, outpacing any other industry.  One out of 
every ten workers is employed in health care related fields. 
 
Massachusetts’ success in expanding health care coverage is rooted in our ongoing 
bipartisan approach to problem solving that includes insurance, business, health 
care, political and advocacy communities and that began in the 1990’s.  At the center 
of that success is our shared belief that health care coverage is a shared 
commitment, not the singular responsibility of government.   
 
As you consider legislation to stabilize premiums and address the individual 
insurance market, I would like to emphasize four key concepts.  
 
Bipartisan Collaboration 
 
First, bipartisan collaboration is going to be essential to achieve affordable health 
care coverage and stabilize the insurance market. The current debate in Washington 
about health care reform has destabilized the insurance market; carriers have 
responded by leaving some markets altogether or proposing to markedly increase 
rates to adjust for the uncertainty.  The majority of Americans support a bipartisan 
approach to stabilizing the market and engaging in meaningful health care reform 
that yields affordable health care coverage. 
 
Market Stabilization  
 
Second, Congress should take immediate affirmative steps to stabilize the insurance 
market as an interim step until longer term reforms are enacted.  Carriers need 
certainty in order to finalize rates for plan year 2018 and begin preparing rates for 
plan year 2019, and providers and employers also need certainty about what those 
rates are going to be.  Month to month resuscitation of cost sharing reductions is not 
stabilization; they should be maintained for at least two years.   
 
I cannot stress enough how critical it is for federal cost sharing reduction payments 
to be resolved affirmatively in order to maintain market stability and to constrain 
rate increases.  It is also important to note that the Congressional Budget Office 
recently reported that ending the cost sharing reduction payments will actually cost 
the federal government more than making the payments, because they will be 
paying out more in premium tax credit subsidies. 
 
As Congress contemplates future reforms, serious consideration should be given to 
reintroducing a reinsurance program as a form of market stabilization.  As you know, 
reinsurance simply reimburses a portion of high cost claims exceeding a given 
attachment point.   
 
A key contributor to market stability is the presence of younger and healthier people 
in the market.  When Massachusetts passed its universal health care law in 2006, it 
included an individual mandate, which I support.  I support it for two reasons.  First 
of all, no one really knows when they might get sick or have a tragic accident, and if 
they do get sick or have an accident, they will seek care, it will be provided, and in 
many circumstances, they will be unable to pay for it.  That means everyone else who 
has insurance will be paying for the health care services rendered to those without 
coverage.  Second, if people have unlimited access to purchase coverage, many will 
purchase health insurance only when they need it, and then drop it once their care is 
provided, defeating the whole point behind insurance coverage. 
 
Insurance coverage is about shared risk.  We all have coverage so that together, we 
can pay for the care provided to the small number of people who need very 
expensive care.  And for those who do get sick, costs can be very high.  It is not 
unusual to have 1% of the population incur 30% of the total cost of care provided to 
that group.  In many cases, 5% of the population incurs 50% of the cost of care 
received by that group. 
 
If people do not have to carry coverage when they are healthy, and can access it only 
when they get sick, break a leg, need to have a procedure, or something else, then 
the rest of us are unfairly tagged with paying for the cost of their care. 
 
Continuous coverage, encouraged one way or another using incentives and 
consequences, is a critical element in ensuring that everyone is treated fairly.  A 
mandate is one way to encourage continuous coverage.  It can also be done using 
financial penalties for people who do not have continuous coverage, or by 
establishing limited open enrollment periods.  Different states can choose different 
approaches – or some combination – but if we want to make it easy for people to 
purchase insurance if they do not have access to it through work, and they don’t 
qualify for public coverage, we need to nudge them into purchasing coverage, and 
keeping it. 
 
Federal/State Partnerships 
 
Third, Congress should establish broader parameters for insurance market reforms 
that include greater latitude for states to meet the unique needs of their 
residents.  States are incubators and innovators of health care reform solutions and 
initiatives in both their Medicaid programs and commercial markets.   
 
States should be allowed to broaden 1332 waivers for greater flexibility.  These 
waivers are still very new tools for states to utilize as they have only been available 
since January 1, 2017.  Massachusetts is committed to providing access to quality, 
affordable health insurance for our residents; rather than walking away from that 
commitment, we believe that increased flexibility would allow us to meet that 
commitment in more effective ways.  In fact, this week,  Massachusetts will be 
submitting a section 1332 waiver seeking additional flexibilities that promote market 
stability with a premium stabilization fund in the event that Congress does not 
appropriate funding of cost sharing reductions.  Additionally, I will be submitting a 
letter to Secretary Price that seeks transitional relief regarding reviving the state’s 
employer shared responsibility program and continuing to use specific state based 
rating factors. Finally, later this year, we will be submitting an additional waiver 
seeking permission to administer the federal small business health care tax credit at 
a state level in order to promote commercial group coverage among small businesses 
with lower wage workers.   
 
I offer the following three examples where changes to 1332 waivers would be of 
significant benefit to states as we continue to reform our health care system.  These 
examples concern essential health benefit compliance, benefit design and budget 
neutrality. Massachusetts is a strong benefit state; we support essential health 
benefits (EHB).  However, even in our state, it was a challenge to adapt to the federal 
framework.  Technical improvements to the process should be allowed that support 
sufficient benefits that comport with best practices and market mechanisms.  A 
prime example of one of these challenges which we still grapple with is the inclusion 
of pediatric dental coverage into the EHB standard.  The need for dental coverage for 
children and youth is not in question, but addressing that need shouldn’t require a 
rigid link between dental and health benefits within the same plan.  EHB required 
that plans sold in the individual and small group market included pediatric dental 
benefits, which has not historically been included in most medical plans.  There can 
be more than one efficient and effective way that states can ensure children covered 
by individual or small group plans are assured access to pediatric dental care.  Even 
today, despite good faith efforts, most of our medical carriers still struggle to 
efficiently integrate dental benefits into their health plans, facing significant technical 
and operational barriers. All of these changes result in the carrier passing the cost 
down to the consumer.  All the while, our dental insurance carriers had been 
providing dental coverage for children, adults and families with proven success and 
with the efficiencies that come with specialization and scale.  It is critical that health 
plans provide coverage for the care that keeps people healthy, but federal mandates 
should leverage common sense market practices and provide states with flexibility to 
match local requirements to local needs.  Federal frameworks can balance local 
experimentation without sacrificing essential benefit categories 
 
Greater flexibility is also needed around benefit design.  Value-Based Insurance 
Design (V-BID) approaches to benefit design seek to align patients’ out-of-pocket 
costs, such as copayments and deductibles, with the value of services. Certain 
technical parameters of EHB make important kinds of benefit design innovation 
difficult. For example, in many areas, bronze and silver plan deductibles are 
extremely close to the maximum out of pocket (MOOP) limits. States may want  to 
experiment with designing plans in which there are lower MOOP levels for  high-
value care (like chronic illness care) in exchange for a slightly higher MOOP overall, 
perhaps exceeding the existing EHB MOOP limit for relatively lower-value services. 
This would help make sure people who opt to buy high deductible plans don't put off 
care that will keep them healthy and also help make sure they don't develop an even 
more costly medical condition. 
 
Finally, the current 1332 regulations require that proposals are examined on their 
own terms with regard to federal deficit neutrality impact.  This can greatly limit 
creative proposals by not allowing commercial innovations to draw from savings 
enabled on the Medicaid program and vice versa.  Opportunities for change could 
range from coupling savings from 1115 and 1332 waivers that are filed together or 
to determine savings over the course of several years.  These types of common 
sense adjustments along with consumer protection guardrails could widen 
opportunities for meaningful innovation and allow for far more comprehensive 
waivers that integrate the ACA, Medicaid and CHIP programs into a coherent health 
care insurance program at the state level.          
In addition to increased flexibility and waiver authority, Massachusetts supports the 
development of “fast-track” waiver authority to expedite federal processing and 
approvals.  
 
Health Care Cost Drivers  
  
Fourth, Congress should take action to address health care costs.  Having achieved 
near universal coverage in Massachusetts, we are now focused on health care 
affordability for individuals, families and employers. As we tackle reforms to the 
health care system, we should bear in mind not just the implications for federal and 
state budgets, but also on the people and businesses struggling to keep up with the 
ever-increasing costs of health care coverage and services. 
 
One critical health care cost driver that Congress should address is rising 
pharmaceutical costs.  In 2013, Massachusetts established a health care cost growth 
benchmark; originally set at 3.6%, it was recently lowered to 3.1%.  Although the 
growth in hospital and physician spending has been near or below the benchmark, 
drug spending is a major driver of health costs, far exceeding the state’s benchmark, 
growing at 8% last year.   
 
Unfortunately, states have limited ability to control pharmaceutical costs. Among 
other actions, Congress should consider safely expediting the FDA approval process, 
increasing competition by ensuring generic drug availability, and creating greater 
opportunities for public payers to negotiate prices.  
 
Medicaid and Other Reforms 
 
While this hearing is focused on insurance market reforms, the prospect of reforms 
to the Medicaid program also looms large.  
 
There are a number of reforms to Medicaid and the Affordable Care Act that would 
be welcomed by many states, including Massachusetts. I look forward to continuing 
to engage with Congress on those ideas. But I cannot support under any 
circumstances any Medicaid reform resulting in a substantial loss of federal revenue 
to Massachusetts and loss of health coverage for thousands of currently insured 
individuals. Additionally, I am opposed to federal sanctions regarding family planning 
and efforts to diminish support for behavioral health and the opioid epidemic. 
 
Closing 
 
As you consider these and other reforms, I ask that Congress introduce any legislative 
changes on a gradual timeline, ideally with state flexibility to opt out or grandfather 
existing programs in order to prevent market shocks and to improve market 
stability.  We are making progress in our  
individual states, innovating with new ideas and we should avoid disrupting ongoing 
systems that work. 
 
Additionally, I urge that whatever reforms are enacted, there be a bipartisan 
commitment to return to the table in the coming years to review and revise those 
reforms.  Complex legislation requires fine-tuning and adjustments, no matter how 
perfect or well-intentioned the legislation is.  In Massachusetts, we have returned to 
health care reform several times since 2006 as we have learned from our 
implementation of the law and as conditions have changed, and our Commonwealth 
is better for it.   
 
Finally, as Congress takes steps to stabilize the insurance market and turn its 
attention to longer term reforms in Medicaid and health insurance markets, we 
should ensure that states have the necessary federal fiscal support to maintain 
important health care services.  This includes stability of funding for cost sharing 
reductions, the reauthorization of the Children’s Health Insurance Program (CHIP), as 
well as the annual discretionary appropriations and Health Centers Fund and a delay 
in the implementation of the proposed Disproportionate Share Hospital 
rule.  Massachusetts currently has approximately 160,000 children on CHIP and 
failure to reauthorize CHIP will cause uncertainty for the families that rely on this 
program for health care services.  Likewise, community health centers are an integral 
part of our health care delivery system, providing access to lower cost care in 
underserved locations.  For many states, including Massachusetts, this core funding 
provides a safety net for many of our lowest income children, adults and families 
which should be protected.   
 
Thank you again for the opportunity to provide testimony on this important issue. I 
look forward to working with you and other members of Congress as you consider 
legislation. 
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